About: Management of infections in critically ill returning travellers in the intensive care unit—II: clinical syndromes and special considerations in immunocompromised patients()

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management of infections in critically ill returning travellers in the intensive care unit—II: clinical syndromes and special considerations in immunocompromised patients() Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management of infections in critically ill returning travellers in the intensive care unit—II: clinical syndromes and special considerations in immunocompromised patients()
Creator	Rello, Jordi Leblebicioglu, Hakan Eggimann, Philippe Manuel, Oriol Richards, Guy Wejse, Christian Zacharowski, Kai Petersen, Jorgen
Source	Elsevier; Medline; PMC
abstract	This position paper is the second ESCMID Consensus Document on this subject and aims to provide intensivists, infectious disease specialists, and emergency physicians with a standardized approach to the management of serious travel-related infections in the intensive care unit (ICU) or the emergency department. This document is a cooperative effort between members of two European Society of Clinical Microbiology and Infectious Diseases (ESCMID) study groups and was coordinated by Hakan Leblebicioglu and Jordi Rello for ESGITM (ESCMID Study Group for Infections in Travellers and Migrants) and ESGCIP (ESCMID Study Group for Infections in Critically Ill Patients), respectively. A relevant expert on the subject of each section prepared the first draft which was then edited and approved by additional members from both ESCMID study groups. This article summarizes considerations regarding clinical syndromes requiring ICU admission in travellers, covering immunocompromised patients.
has issue date	2016-04-28(xsd:dateTime)
bibo:doi	10.1016/j.ijid.2016.04.020
bibo:pmid	27134159
has license	no-cc
sha1sum (hex)	ddff43b2dc51c88c59b110df02735bcaf5fbc760
schema:url	https://doi.org/10.1016/j.ijid.2016.04.020
resource representing a document's title	Management of infections in critically ill returning travellers in the intensive care unit—II: clinical syndromes and special considerations in immunocompromised patients()
has PubMed Central identifier	PMC7110459
has PubMed identifier	27134159
schema:publication	Int J Infect Dis
resource representing a document's body	covid:ddff43b2dc51c88c59b110df02735bcaf5fbc760#body_text
is schema:about of	named entity 'INFECTIONS' named entity 'intensive care' named entity 'CLINICAL SYNDROMES' named entity 'CRITICALLY ILL' named entity 'MANAGEMENT' named entity 'IMMUNOCOMPROMISED PATIENTS' named entity 'INTENSIVE CARE UNIT' named entity 'SPECIAL' named entity 'CONSIDERATIONS' named entity 'intensive care unit' named entity 'drugs of choice' named entity 'Disseminated intravascular coagulation' named entity 'intensive care unit' named entity 'septicaemia' named entity 'immunocompromised' named entity 'DIC' named entity 'biologicals' named entity 'camel milk' named entity 'dengue' named entity 'hyponatremia' named entity 'neutropenia' named entity 'morbid obesity' named entity 'fever' named entity 'lupus' named entity 'acute respiratory failure' named entity 'renal failure' named entity 'incubation period' named entity 'infection' named entity 'intubation' named entity 'MRSA' named entity 'Southeast Asia' named entity 'comorbidities' named entity 'ARDS' named entity 'haematological' named entity 'Canada' named entity 'central nervous' named entity 'pyrexia' named entity 'eastern Thailand' named entity 'Clinical Microbiology' named entity 'influenza' named entity 'Penicillium marneffei' named entity 'North American' named entity 'Hong Kong' named entity 'MERS-CoV' named entity 'Non-infectious' named entity 'ICU' named entity 'infection control' named entity 'mortality rate' named entity 'H5N1' named entity 'rifampicin' named entity 'PCR' named entity 'pneumonia' named entity 'ESCMID' named entity 'immunosuppression' named entity 'blood vessels' named entity 'bacterial pneumonia' named entity 'COP' named entity 'kinase' named entity 'West Nile virus infection' named entity 'kidney function' named entity 'case reports' named entity 'virus' named entity 'quinolones' named entity 'high-risk' named entity 'ECMO' named entity 'DIC' named entity 'haemorrhage' named entity 'septicaemia' named entity 'immunosuppressive' named entity 'immunosuppression' named entity 'immunocompromised' named entity 'endemic diseases' named entity 'respiratory complications' named entity 'MRSA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software